Published in J Clin Pathol on April 01, 1988
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 7.91
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med (2010) 3.44
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol (2007) 3.33
Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci U S A (2010) 2.66
Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis. Am J Respir Crit Care Med (2014) 2.13
Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax (1995) 2.04
Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol (2001) 1.96
LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res (2013) 1.91
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol (2009) 1.86
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.64
Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition. Crit Care Med (2012) 1.63
Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol (2004) 1.56
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice. Respir Res (2008) 1.56
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol (2005) 1.53
Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int J Radiat Oncol Biol Phys (2007) 1.46
OX40L blockade protects against inflammation-driven fibrosis. Proc Natl Acad Sci U S A (2016) 1.42
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J Clin Invest (2009) 1.41
Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest (1996) 1.41
Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic Biol Med (2007) 1.37
Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage. Free Radic Biol Med (2010) 1.35
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol (2010) 1.27
Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 1.24
CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol (2008) 1.23
Characterization of the innate immune response to chronic aspiration in a novel rodent model. Respir Res (2007) 1.22
Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res (2010) 1.21
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Exp Mol Med (2010) 1.21
Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease. PLoS One (2013) 1.20
A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule. Health Phys (2012) 1.19
Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition. FASEB J (2011) 1.19
The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clin Invest (1997) 1.19
Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. J Immunol (2010) 1.17
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev (2011) 1.14
Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One (2012) 1.14
Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosis. Am J Respir Cell Mol Biol (2007) 1.13
The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells (2011) 1.12
Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. Int J Biochem Cell Biol (2007) 1.11
Activation of the Wnt/β-catenin signaling pathway by mechanical ventilation is associated with ventilator-induced pulmonary fibrosis in healthy lungs. PLoS One (2011) 1.08
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum (2011) 1.08
The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis. Genes Dev (2014) 1.08
Nrf2 amplifies oxidative stress via induction of Klf9. Mol Cell (2014) 1.08
A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice. Respir Res (2010) 1.07
Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol (2010) 1.07
Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 1.06
Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS One (2011) 1.06
PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am J Pathol (2001) 1.05
Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury. Am J Respir Crit Care Med (2008) 1.05
8-Oxoguanine-DNA glycosylase 1 deficiency modifies allergic airway inflammation by regulating STAT6 and IL-4 in cells and in mice. Free Radic Biol Med (2011) 1.04
Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis. Respir Res (2008) 1.02
Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One (2010) 1.01
Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med (2009) 1.01
Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir Res (2005) 1.01
Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. FASEB J (2013) 1.01
Comparison between conventional and "clinical" assessment of experimental lung fibrosis. J Transl Med (2008) 1.00
Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury. Am J Pathol (2010) 0.99
Molecular magnetic resonance imaging of pulmonary fibrosis in mice. Am J Respir Cell Mol Biol (2013) 0.99
Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study. Respir Res (2009) 0.99
Efficacy of a novel class of RNA interference therapeutic agents. PLoS One (2012) 0.99
NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. Br J Cancer (2006) 0.98
Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 0.98
Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci (2012) 0.98
Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction. Am J Physiol Lung Cell Mol Physiol (2011) 0.97
Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review. BMC Vet Res (2013) 0.97
Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. Eur J Immunol (2013) 0.96
Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1. Respir Res (2010) 0.96
Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury. Br J Pharmacol (2009) 0.96
Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clin Exp Immunol (2004) 0.95
Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis. Am J Pathol (2010) 0.95
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Respir Res (2006) 0.95
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respir Res (2006) 0.94
Critical role for IL-18 in spontaneous lung inflammation caused by autophagy deficiency. J Immunol (2015) 0.93
Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis. J Clin Pathol (2006) 0.93
Association between heat stress protein 70 induction and decreased pulmonary fibrosis in an animal model of acute lung injury. Lung (2007) 0.93
Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Respir Res (2014) 0.93
Pulmonary fibrosis induced by H5N1 viral infection in mice. Respir Res (2009) 0.93
Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis. Respir Res (2011) 0.92
Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats. Respir Res (2013) 0.92
Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am J Respir Cell Mol Biol (2010) 0.92
Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS One (2013) 0.92
Development of a small animal model to simulate clinical stereotactic body radiotherapy-induced central and peripheral lung injuries. J Radiat Res (2014) 0.91
A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol (2008) 0.91
MEK inhibition suppresses the development of lung fibrosis in the bleomycin model. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.91
Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis. Am J Pathol (2006) 0.90
Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice. PLoS One (2014) 0.90
Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats. Inflammation (2012) 0.90
Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. Respir Res (2011) 0.89
Yin yang 1 is a novel regulator of pulmonary fibrosis. Am J Respir Crit Care Med (2010) 0.89
Nonhomogeneous density of CD34 and VCAM-1 alveolar capillaries in major types of idiopathic interstitial pneumonia. Lung (2006) 0.89
Corilagin attenuates aerosol bleomycin-induced experimental lung injury. Int J Mol Sci (2014) 0.89
Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent. Strahlenther Onkol (2012) 0.87
Lung bone marrow-derived hematopoietic progenitor cells enhance pulmonary fibrosis. Am J Respir Crit Care Med (2013) 0.87
Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis. Transl Res (2015) 0.87
The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. J Clin Pathol (2005) 0.87
Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin. Am J Respir Cell Mol Biol (2015) 0.87
Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats. Respir Res (2009) 0.86
Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity. Thorax (2011) 0.86
Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis. Med Mol Morphol (2007) 0.86
Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis. Clin Exp Immunol (2010) 0.86
Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir Res (2011) 0.86
Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage. PLoS One (2013) 0.86
Genome-wide transcriptional response during the development of bleomycin-induced pulmonary fibrosis in sprague-dawley rats. Toxicol Res (2010) 0.85
The effects of the inhalation of asbestos in rats. Br J Cancer (1974) 5.57
Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer (1973) 4.46
Evaluation of two school smoking education programmes under normal classroom conditions. BMJ (1993) 3.83
UICC standard reference samples of asbestos. Int J Cancer (1968) 3.42
Mass media-led antismoking campaign can remove the education gap in quitting behavior. Am J Public Health (1992) 3.08
Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) (1985) 2.97
Levator trauma is associated with pelvic organ prolapse. BJOG (2008) 2.55
Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis (1987) 2.29
The effect of fibre size on the in vitro biological activity of three types of amphibole asbestos. Int J Cancer (1978) 2.24
Survey on developmental-behavioural training experiences of Australian paediatric advanced trainees. J Paediatr Child Health (1994) 2.01
Human exposure to asbestos: dust controls and standards. The inhalation of fibrous dusts. Ann N Y Acad Sci (1965) 1.98
An evaluation of length and end-phrase of visual analogue scales in dental pain. Pain (1985) 1.92
Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med (1991) 1.90
Epidemiology of asbestos cancers. Br Med Bull (1971) 1.84
PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire. J Clin Epidemiol (1995) 1.77
Australasian perfusion incident survey. Perfusion (1997) 1.72
Observations on the pathogenesis of experimental Salmonella typhimurium infection in chickens. Res Vet Sci (1987) 1.64
Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet (2007) 1.59
Deposition and retention of fibres in the human lung. Ann Occup Hyg (1982) 1.58
Visual impairment, age-related cataract, and mortality. Arch Ophthalmol (2001) 1.55
Atopy phenotypes in the Childhood Asthma Prevention Study (CAPS) cohort and the relationship with allergic disease: clinical mechanisms in allergic disease. Clin Exp Allergy (2013) 1.50
Comparison between allograft plus demineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study. Spine (Phila Pa 1976) (1995) 1.50
A simple dispenser for generating dust clouds from standard reference samples of asbestos. Ann Occup Hyg (1968) 1.47
Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol (1983) 1.47
Molecular ecological analysis of dietary and antibiotic-induced alterations of the mouse intestinal microbiota. J Nutr (2001) 1.47
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J (Clin Res Ed) (1987) 1.46
Contribution of Salmonella gallinarum large plasmid toward virulence in fowl typhoid. Infect Immun (1987) 1.41
The relationship between intelligence and duration of circulatory arrest with deep hypothermia. J Thorac Cardiovasc Surg (1995) 1.40
Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom. Q J Med (1986) 1.39
Three-dimensional fetal echocardiography for prediction of postnatal surgical approach in double outlet right ventricle: a pilot study. Ultrasound Obstet Gynecol (2013) 1.39
Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant (2007) 1.37
Anatomical variations in the first extensor compartment of the wrist. A clinical and anatomical study. J Bone Joint Surg Am (1986) 1.35
Perinatal risk factors for major intraventricular haemorrhage in the Australian and New Zealand Neonatal Network, 1995-97. Arch Dis Child Fetal Neonatal Ed (2002) 1.30
Timing of presentation and postnatal outcome of infants suspected of having coarctation of the aorta during fetal life. Heart (2005) 1.25
Composite cardiovascular risk outcomes of a work-site intervention trial. Am J Public Health (1997) 1.24
Inhibition of colonization of the chicken alimentary tract with Salmonella typhimurium gram-negative facultatively anaerobic bacteria. Epidemiol Infect (1987) 1.21
Trends in induction of labour, 1998-2007: a population-based study. Aust N Z J Obstet Gynaecol (2009) 1.21
Work-site cardiovascular risk reduction: a randomized trial of health risk assessment, education, counseling, and incentives. Am J Public Health (1993) 1.21
Fetal dextrocardia: diagnosis and outcome in two tertiary centres. Heart (2005) 1.19
Sources of lead poisoning. JAMA (1984) 1.18
Efficient study designs to assess the accuracy of screening tests. Am J Epidemiol (1994) 1.15
Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart (2003) 1.14
Revelation by single-nucleotide polymorphism genotyping that mutations leading to a premature stop codon in inlA are common among Listeria monocytogenes isolates from ready-to-eat foods but not human listeriosis cases. Appl Environ Microbiol (2010) 1.14
Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int (2007) 1.11
Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect (1999) 1.07
Comparison of smoking habits between patients with surgically confirmed herniated lumbar and cervical disc disease and controls. J Spinal Disord (1994) 1.06
The comparative sensitivity of mammography and ultrasound in women with breast symptoms: an age-specific analysis. Breast (2002) 1.05
Prenatal predictors of chronic lung disease in very preterm infants. Arch Dis Child Fetal Neonatal Ed (2005) 1.04
The respirability of aerosols produced in dentistry. J Dent (1973) 1.04
Outcome after preterm delivery of infants antenatally diagnosed with congenital heart disease. J Pediatr (2006) 1.04
Prenatal predictors of mortality in very preterm infants cared for in the Australian and New Zealand Neonatal Network. Arch Dis Child Fetal Neonatal Ed (2006) 1.03
Spermatogenesis without gonadotropins: maintenance has a lower testosterone threshold than initiation. Endocrinology (1999) 1.03
Intestinal colonisation in the chicken by food-poisoning Salmonella serotypes; microbial characteristics associated with faecal excretion. Avian Pathol (1988) 1.03
Elevated blood lead levels in children--a 27-city neighborhood survey. Health Serv Rep (1973) 1.02
Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord (2006) 1.01
Environmental factors in childhood IDDM. A population-based, case-control study. Diabetes Care (1994) 1.00
Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol (1996) 0.98
Encouraging attendance at screening mammography: knowledge, attitudes and intentions of general practitioners. Med J Aust (1989) 0.97
Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are specific to the ventral dentate gyrus. Neurobiol Dis (2009) 0.97
Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed (1999) 0.97
A comparative study of the mannose-resistant and mannose-sensitive haemagglutinins of Escherichia coli isolated from urinary tract infections. Infection (1983) 0.96
Hollow casts of lungs for experimental purposes. Nature (1970) 0.96
Outpatient laminotomy and discectomy. J Spinal Disord (1999) 0.95
Variation in rates of severe retinopathy of prematurity among neonatal intensive care units in the Australian and New Zealand Neonatal Network. Br J Ophthalmol (2005) 0.95
Low lumbar burst fractures: comparison between conservative and surgical treatments. Orthopedics (1992) 0.95
Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos Int (2010) 0.94
Work-site cholesterol screening and dietary intervention: the Staff Healthy Heart Project. Steering Committee. Am J Public Health (1994) 0.94
Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome. Arch Dis Child (1991) 0.93
Estimation of environmental and genetic components of quantitative traits with application to serum cholesterol levels. Am J Hum Genet (1981) 0.93
Interobserver agreement in detailed prenatal diagnosis of congenital heart disease by telemedicine using four-dimensional ultrasound with spatiotemporal image correlation. Ultrasound Obstet Gynecol (2012) 0.92
Hypoplastic left heart syndrome. Ultrasound Obstet Gynecol (2000) 0.92
Progression and regression of low-grade epithelial abnormalities of the cervix. Aust N Z J Obstet Gynaecol (1997) 0.92
Evaluation of a mass-media-led campaign to increase Pap smear screening. Health Educ Res (1991) 0.92
Pneumopericardium presenting as reduced ECG voltages. Heart (2005) 0.92
Transient swelling versus lymphoedema in the first year following surgery for breast cancer. Support Care Cancer (2013) 0.91
The contribution of work-up or additional views to the accuracy of diagnostic mammography. Breast (2003) 0.91
Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int (2011) 0.91
Significant shift in median guinea pig infectious dose shown by an outbreak-associated Listeria monocytogenes epidemic clone strain and a strain carrying a premature stop codon mutation in inlA. Appl Environ Microbiol (2011) 0.91
Autonomic and peripheral nerve function in adolescents with and without diabetes. Diabet Med (1993) 0.91
Intellectual function and age of repair in cyanotic congenital heart disease. Arch Dis Child (1995) 0.90
A prospective cohort study investigating psychosocial predictors of attendance at a mobile breast screening service. Aust J Public Health (1995) 0.90
Pupillary abnormalities in type I diabetes occurring during adolescence. Comparisons with cardiovascular reflexes. Diabetes Care (1993) 0.90
Who comes to a workplace health risk assessment? Int J Behav Med (1998) 0.89
Spatial disorientation in general aviation accidents. Aviat Space Environ Med (1978) 0.89
Detailed three-dimensional fetal echocardiography facilitated by an Internet link. Ultrasound Obstet Gynecol (2001) 0.88
Body mass index, sexual difficulties and sexual satisfaction among people in regular heterosexual relationships: a population-based study. Intern Med J (2012) 0.88
Susceptibility and amplification of sensitivity in contact dermatitis. Clin Exp Immunol (1985) 0.87
Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev (2007) 0.87
Asking the right questions of disadvantaged and homeless communities: the role of housing, patterns of illness and reporting behaviours in the measurement of health status. Aust N Z J Public Health (2001) 0.87
The SF-36 walk-wheel: a simple modification of the SF-36 physical domain improves its responsiveness for measuring health status change in spinal cord injury. Spinal Cord (2008) 0.87
Predicting operative delivery. Ultrasound Obstet Gynecol (2006) 0.86
The effect of altering area of application and dose per unit area on sensitization by DNCB. Br J Dermatol (1986) 0.86
Infant and early childhood dietary predictors of overweight at age 8 years in the CAPS population. Eur J Clin Nutr (2011) 0.86
Echocardiographic features and outcome of truncus arteriosus diagnosed during fetal life. Am J Cardiol (2001) 0.86
Retrospective prenatal diagnosis of scimitar syndrome aided by three-dimensional power Doppler imaging. Ultrasound Obstet Gynecol (2001) 0.85
Primary dapsone chemoprophylaxis for Pneumocystis carinii pneumonia in immunocompromised patients infected with the human immunodeficiency virus. Med J Aust (1989) 0.85
Plastic bronchitis; a serious complication of the Fontan operation. Int J Cardiol (2005) 0.85
Fetal arrhythmias. Ultrasound Obstet Gynecol (2006) 0.84
Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer. Br J Surg (1994) 0.84
Parent and teacher perceptions of child behaviour following cardiac surgery. Acta Paediatr (1994) 0.84